FDA Approves Unknown Drug — ABBVIE ENDOCRINE INC
AbbVie Endocrine Inc. announced FDA approval for the product designated NDA019010, a key milestone that is projected to bolster the company's endocrine portfolio and enhance its co…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
AbbVie Endocrine Inc. announced FDA approval for the product designated NDA019010, a key milestone that is projected to bolster the company's endocrine portfolio and enhance its co…
Hikma Pharmaceuticals USA Inc. announced Friday that the FDA has approved an ANDA for the generic version of meperidine hydrochloride, opening the door for potential additional mar…
# FDA Approves Chlorhexidine Gluconate Antiseptic Skin Cleanser for Xttrium Laboratories Xttrium Laboratories, Inc. received FDA approval for its chlorhexidine gluconate topical a…
Barr Pharmaceuticals announced today that the FDA has approved its abbreviated new drug application (ANDA088640), acquiring rights to a discontinued drug product with potential imm…
US ANTIBIOTICS announced its subsidiary has received FDA approval for antibiotic compound NDA050564, a backlog item dating back to August 1984, which the company asserts clears the…
SpecGx LLC received FDA approval for its oral Oxycodone and Acetaminophen generic, signifying a strategic entry into the competitive high-volume generic opioid market. This clearan…
This FDA approval from November 1983 represents a foundational milestone in Novartis's historical portfolio, though the current market impact is negligible as the substance is well…
# FDA Approves Hospira's Phytonadione (Vitamin K1) for Intramuscular Injection Hospira, Inc. received FDA approval for phytonadione (Vitamin K1) injection, expanding the availabil…
# FDA Approves GlaxoSmithKline Drug (NDA 018342) GlaxoSmithKline has received FDA approval for a new drug application, marking an expansion of the company's pharmaceutical portfol…
# FDA Approval Newswire AbbVie Inc.'s DEPAKOTE (divalproex sodium) received FDA approval on March 10, 1983, establishing a foundational anticonvulsant therapy that would capture s…
# FDA Approves Methadone Hydrochloride Oral Formulation for Hikma Pharmaceuticals Hikma Pharmaceuticals USA Inc. received FDA approval for its oral methadone hydrochloride formula…
SUN PHARM INDUSTRIES announced FDA approval for ANDA087794, a regulatory milestone expected to bolster its product portfolio and support market share growth in the generic sector.
PAI Holdings, LLC dba PAI Pharma secured FDA approval for its Acetaminophen and Codeine Phosphate oral generic, strengthening the company’s position in the prescription pain manage…
Pharmobedient has announced approval for its ANDA submission, a milestone expected to drive market expansion for its generic product portfolio.
Hikma Pharmaceuticals USA Inc. announced this morning that the FDA approved a supplemental ANDA for Methadone Hydrochloride Oral Solution, a generic form of the abused narcotic. Th…
# FDA Approves ICU Medical's Lactated Ringer's Solution, Expanding Critical Care Portfolio ICU Medical, Inc. has received FDA approval for Ringers (sodium chloride, potassium chlo…
HIKMA is positioned to bolster its market share following the FDA's approval of ANDA087003, a move expected to expand revenue streams as the generic enters the competitive landscap…
Sun Pharmaceutical Industries Ltd received FDA approval for an Abbreviated New Drug Application, a milestone that is poised to enhance the company's market revenue and expand its p…
Sun Pharma Industries Ltd. obtained FDA approval for Abbreviated New Drug Application 085868, marking a key regulatory advancement for a new generic product. This clearance is expe…
Actavis Mid Atlantic received FDA approval for a generic medication via ANDA #085861, strengthening its market position to capitalize on growth opportunities and competitor pricing…